Moving from Lab to Large-Scale Supply in Peptide API Manufacturing
Latest News & Resources
CPC Scientific is pleased to announce that its parent company Medtide Inc. (HKEX: 3880.HK) has recently received certification through EcoVadis, a global leader in business sustainability assessments.
CPC Scientific is pleased to announce that its parent company Medtide Inc. (HKEX: 3880.HK) has recently received certification through EcoVadis, a global leader in business sustainability assessments.
CPC Scientific had a fantastic time connecting with partners, clients, and colleagues this year at DCAT Week 2026. See our highlights from New York, featuring generic API scale-up, the 98th DCAT Annual Dinner, and more...
Catch CPC Scientific's key moments from NextGen Biomed 2026, where we showcased how our advanced process design is accelerating production timelines and cost efficiency for greener TIDES manufacturing at scale...
Discover how CPC Scientific has earned the trust of top pharma and biotech companies across 50+ countries. See the numbers behind our GMP regulatory record, global project portfolio, clinical and commercial delivery timelines, and more.
Peptide and oligonucleotide APIs are driving a new generation of pharmaceutical drug development. Learn more about the API manufacturing process and why it matters to partner with a specialized peptide and oligonucleotide CDMO.
CPC Scientific is pleased to announce that its parent company Medtide Inc. (HKEX: 3880.HK) has recently received certification through EcoVadis, a global leader in business sustainability assessments.
CPC Scientific is pleased to announce that its parent company Medtide Inc. (HKEX: 3880.HK) has recently received certification through EcoVadis, a global leader in business sustainability assessments.
CPC Scientific had a fantastic time connecting with partners, clients, and colleagues this year at DCAT Week 2026. See our highlights from New York, featuring generic API scale-up, the 98th DCAT Annual Dinner, and more...
Catch CPC Scientific's key moments from NextGen Biomed 2026, where we showcased how our advanced process design is accelerating production timelines and cost efficiency for greener TIDES manufacturing at scale...
Discover how CPC Scientific has earned the trust of top pharma and biotech companies across 50+ countries. See the numbers behind our GMP regulatory record, global project portfolio, clinical and commercial delivery timelines, and more.
Peptide and oligonucleotide APIs are driving a new generation of pharmaceutical drug development. Learn more about the API manufacturing process and why it matters to partner with a specialized peptide and oligonucleotide CDMO.
